Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.
The mechanisms by which aniline exposure elicits splenotoxic response, especially the tumorigenic response, are not well-understood. Splenotoxicity of aniline is associated with iron overload and generation of reactive oxygen species (ROS) which can cause oxidative damage to DNA, proteins and lipids (oxidative stress). 8-Hydroxy-2'-deoxyguanosine (8-OHdG) is one of the most abundant oxidative DNA lesions resulting from ROS, and 8-oxoguanine glycosylase 1 (OGG1), a specific DNA glycosylase/lyase enzyme, plays a key role in the removal of 8-OHdG adducts. This study focused on examining DNA damage (8-OHdG) and repair (OGG1) in the spleen in an experimental condition preceding a tumorigenic response. To achieve that, male Sprague-Dawley rats were subchronically exposed to aniline (0.5 mmol/kg/day via drinking water for 30 days), while controls received drinking water only. Aniline treatment led to a significant increase in splenic oxidative DNA damage, manifested as a 2.8-fold increase in 8-OHdG levels. DNA repair activity, measured as OGG1 base excision repair (BER) activity, increased by approximately 1.3 fold in the nuclear protein extracts (NE) and approximately 1.2 fold in the mitochondrial protein extracts (ME) of spleens from aniline-treated rats as compared to the controls. Real-time PCR analysis for OGG1 mRNA expression in the spleen revealed a 2-fold increase in expression in aniline-treated rats than the controls. Likewise, OGG1 protein expression in the NEs of spleens from aniline-treated rats was approximately 1.5 fold higher, whereas in the MEs it was approximately 1.3 fold higher than the controls. Aniline treatment also led to stronger immunostaining for both 8-OHdG and OGG1 in the spleens, confined to the red pulp areas. It is thus evident from our studies that aniline-induced oxidative stress is associated with increased oxidative DNA damage. The BER pathway was also activated, but not enough to prevent the accumulation of oxidative DNA damage (8-OHdG). Accumulation of mutagenic oxidative DNA lesions in the spleen following exposure to aniline could play a critical role in the tumorigenic process.
Ma
Huaxian
H
Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0438, USA.
Wang
Jianling
J
Abdel-Rahman
Sherif Z
SZ
Boor
Paul J
PJ
Khan
M Firoze
MF
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000814:Aniline Compounds / Q000633:toxicity*; D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D004249:DNA Damage / Q000187:drug effects*; D045647:DNA Glycosylases / Q000378:metabolism; D004260:DNA Repair; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D008297:Male; D024101:Mitochondrial Proteins / Q000378:metabolism; D009153:Mutagens / Q000633:toxicity; D009687:Nuclear Proteins / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013154:Spleen / Q000187:drug effects* / Q000473:pathology
D000814:Aniline Compounds; D002273:Carcinogens; D024101:Mitochondrial Proteins; D009153:Mutagens; D009687:Nuclear Proteins; D012333:RNA, Messenger; D000080242:8-Hydroxy-2'-Deoxyguanosine; D045647:DNA Glycosylases; C483741:OGG1 protein, rat; D003849:Deoxyguanosine; C023650:aniline
J Biol Chem. 1992 Jan 5;267(1):166-72
1730583
Carcinogenesis. 2007 Aug;28(8):1629-37
17389610
Carcinogenesis. 1998 Jun;19(6):1053-9
9667744
Prog Nucleic Acid Res Mol Biol. 2001;68:41-54
11554312
Nucleic Acids Res. 2001 Jan 15;29(2):430-8
11139613
Nucleic Acids Res. 2004 Aug 13;32(14):4332-9
15310837
J Clin Invest. 2002 Jan;109(1):3-6
11781342
J Natl Cancer Inst. 1984 Jul;73(1):265-73
6588231
Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):86-93
16169568
Int J Cancer. 2005 Mar 10;114(1):153-6
15523686
Toxicol Appl Pharmacol. 2008 May 1;228(3):395-402
18234257
Carcinogenesis. 2001 Sep;22(9):1459-63
11532868
Nature. 2000 Feb 24;403(6772):859-66
10706276
J Toxicol Environ Health A. 2005 Apr 23;68(8):657-66
15901093
Methods. 2001 Dec;25(4):443-51
11846613
Mol Vis. 2000 Oct 05;6:178-83
11023552
Nucleic Acids Res. 1998 Nov 15;26(22):5116-22
9801308
Cancer Res. 2003 Aug 15;63(16):4899-902
12941813
Arch Environ Contam Toxicol. 1993 Apr;24(3):368-74
8470936
J Toxicol Environ Health A. 2003 Jan 10;66(1):93-102
12587293
Mol Carcinog. 1999 Dec;26(4):254-60
10569802
Cancer Res. 1994 Apr 1;54(7 Suppl):1890s-1894s
8137306
Toxicol Appl Pharmacol. 2005 Feb 15;203(1):36-44
15694462
Free Radic Biol Med. 2001 Dec 1;31(11):1465-72
11728819
Am J Physiol Cell Physiol. 2008 Feb;294(2):C413-22
18077603
Clin Cancer Res. 2000 Apr;6(4):1394-400
10778969
Oncogene. 1998 Jun 11;16(23):3083-6
9662341
Carcinogenesis. 2004 Nov;25(11):2177-81
15284179
Toxicology. 2002 May 1;173(3):193-201
11960672
Toxicol Sci. 1999 Mar;48(1):134-40
10330693
Annu Rev Genet. 2004;38:445-76
15568983
Toxicol Sci. 2004 Sep;81(1):198-215
15187235
Mol Gen Genet. 1997 Mar 26;254(2):171-8
9108279
Nucleic Acids Res. 1999 Oct 15;27(20):4001-7
10497264
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8010-5
9223305
Carcinogenesis. 1990 Sep;11(9):1447-50
2205403
Free Radic Biol Med. 2001 Apr 15;30(8):916-23
11295534
Toxicol Appl Pharmacol. 2008 Jul 15;230(2):227-34
18420242
Biochemistry. 1991 Jan 8;30(1):207-13
1703014
J Toxicol Environ Health A. 1999 Jun 11;57(3):173-84
10376884
Free Radic Biol Med. 1996;20(4):553-66
8904296
Food Chem Toxicol. 1987 Aug;25(8):619-26
3305247
J Natl Cancer Inst. 2003 Sep 3;95(17):1263-5
12953074
Arch Biochem Biophys. 2000 May 1;377(1):1-8
10775435
Mech Ageing Dev. 2006 Jan;127(1):64-9
16257035
J Natl Cancer Inst. 1985 Oct;75(4):681-90
3862900
Mutat Res. 2002 Nov 30;509(1-2):127-51
12427535
Antioxid Redox Signal. 2008 May;10(5):891-937
18205545
Jpn J Cancer Res. 2000 Jul;91(7):681-5
10920274
Mol Cell Biol. 2006 Mar;26(5):1654-65
16478987
J Natl Cancer Inst. 1985 Jul;75(1):81-4
2989605
FASEB J. 2003 Jul;17(10):1195-214
12832285
Fundam Appl Toxicol. 1997 Jan;35(1):22-30
9024670